VMX eye drops for dry eye
Part of Eyes & vision clinical trials.
This trial tests a new type of eye drop (called VMX) to see if it helps people with mild to moderate dry eye. The study will compare how well the eye drops work and if they are safe for you to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have mild or moderate dry eye, diagnosed by a doctor.
- You must be willing to stop using all artificial tears for at least 7 days before the trial starts and for the whole trial.
- You must not have had any eye surgery in the past 12 months.
- You must not have autoimmune diseases like Sjögren's syndrome or rheumatoid arthritis.
- You must not take certain medications that affect dry eye (like allergy pills, decongestants, or certain acne medications) within a month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This trial tests an experimental eye drop (RCI001) to see if it's better than a placebo at relieving dry eye symptoms. It might help if you have moderate to severe dry eye and are looking for a new treatment.
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
This study tests new artificial tear drops to see if they are safe and effective for people with dry eye disease. If you have dry eyes, these drops might help reduce symptoms and improve eye comfort.
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
Hear when a new Dry Eye Disease (DED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.